Kellerhals Carrard advised Roland Bays in the sale of Medlight to Rakuten Medical

Kellerhals Carrard advised Roland Bays, founder and CEO of Medlight, in the sale of his company to Rakuten Medical.

Medlight produces and commercializes a large range of optical fiber based catheters for accurate illumination of tissue, used in new tumor treatments based on light energy.

Rakuten Medical is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in preclinical studies, have shown to lead to rapid and selective cell killing and tumor necrosis.

The team 


The Kellerhals Carrard team was composed of Frédéric Rochat (pictured), Elena Burger and Shima Gennari.

As previously announced by, Lenz & Staehelin advised Rakuten Medical in the acquisition of Medlight

Kellerhals Carrard advised Roland Bays in the sale of Medlight to Rakuten Medical


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram